QOL
Axicabtagene Ciloleucel CAR-T Treatment Improved Quality of Life Over Standard of Care in R/R LBCL
Cecilia BrownAggressive B-Cell Lymphoma | November 22, 2022
Axicabtagene ciloleucel, an autologous anti-CD19 CAR T-cell treatment, improved quality of life compared to standard of care ...
Read More
Late Effects of Treatment Linked with QOL in Long-Term Lymphoma Survivors
Leah LawrenceHodgkin Lymphoma | November 14, 2022
Long-term lymphoma survivors who underwent transplant had impaired health-related quality of life.
Read More
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |